Literature DB >> 20963419

Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis.

Xiaoqian Liu1, Chunde Bao, Dawei Hu.   

Abstract

There is evidence that interleukin-18 plays a role in lupus nephritis (LN). Since interleukin -18 (IL-18) promotes polarization of the immune response toward Th1, we investigated level of IL-18 and assessed the phenotypic distribution of Th1 and Th2 type cells in LN. A predominance of Th1 type (IFN-γ+) cells and significant correlations with serum IL-18 was seen in the patients with LN compared to healthy controls. Although most patients were treated with high dosage of glucocorticoid and other immunosuppressive agents, higher level of IL-18 was found in both serum and glomeruli. However, there was no paralleled upregulation of its gene expression in peripheral blood mononuclear cells. Our findings indicate that the elevated IL-18 should be a symbol of disease activity and play a major role in the pathogenesis of LN by promoting cytokine imbalance towards Th1 type immune response. We conclude that patients with LN would benefit from it while the bioactivity of this cytokine was effectively counteracted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963419     DOI: 10.1007/s00296-010-1609-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

1.  Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids.

Authors:  Hideki Miyaura; Makoto Iwata
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Circulating levels of beta-chemokines in systemic lupus erythematosus.

Authors:  H Kaneko; H Ogasawara; T Naito; H Akimoto; S Lee; T Hishikawa; I Sekigawa; Y Tokano; Y Takasaki; S I Hirose; H Hashimoto
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

4.  Predominance of Th1 immune response in diffuse proliferative lupus nephritis.

Authors:  K Masutani; M Akahoshi; K Tsuruya; M Tokumoto; T Ninomiya; T Kohsaka; K Fukuda; H Kanai; H Nakashima; T Otsuka; H Hirakata
Journal:  Arthritis Rheum       Date:  2001-09

5.  Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus.

Authors:  M Akahoshi; H Nakashima; Y Tanaka; T Kohsaka; S Nagano; E Ohgami; Y Arinobu; K Yamaoka; H Niiro; M Shinozaki; H Hirakata; T Horiuchi; T Otsuka; Y Niho
Journal:  Arthritis Rheum       Date:  1999-08

Review 6.  Interleukin-18.

Authors:  C A Dinarello
Journal:  Methods       Date:  1999-09       Impact factor: 3.608

7.  Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis.

Authors:  D Y Chen; C W Hsieh; K S Chen; Y M Chen; F J Lin; J L Lan
Journal:  Lupus       Date:  2009-01       Impact factor: 2.911

8.  IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE.

Authors:  Teresa Warchoł; Margarita Lianeri; Mariusz Wudarski; Jan K Lacki; Paweł Piotr Jagodziński
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 9.  Cytokines in the pathogenesis of systemic lupus erythematosus.

Authors:  V R Kelley; R P Wüthrich
Journal:  Semin Nephrol       Date:  1999-01       Impact factor: 5.299

10.  Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus.

Authors:  Elena Sánchez; Rogelio J Palomino-Morales; Norberto Ortego-Centeno; Juan Jiménez-Alonso; Miguel A González-Gay; Miguel A López-Nevot; Julio Sánchez-Román; Enrique de Ramón; M Francisca González-Escribano; Bernardo A Pons-Estel; Sandra D'Alfonso; Gian Domenico Sebastiani; Marta E Alarcón-Riquelme; Javier Martín
Journal:  Hum Mol Genet       Date:  2009-07-07       Impact factor: 6.150

View more
  7 in total

Review 1.  The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.

Authors:  Hui Bao; Ai Peng
Journal:  J Transl Int Med       Date:  2016-09-23

2.  An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.

Authors:  J Michelle Kahlenberg; Srilakshmi Yalavarthi; Wenpu Zhao; Jeffrey B Hodgin; Tamra J Reed; Noriko M Tsuji; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

3.  Elevated Interleukin-18 Receptor Accessory Protein Mediates Enhancement in Reactive Oxygen Species Production in Neutrophils of Systemic Lupus Erythematosus Patients.

Authors:  Jie Ma; Ian Kar Yin Lam; Chak-Sing Lau; Vera Sau Fong Chan
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

4.  Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han Population.

Authors:  Keshav Raj Sigdel; Lihua Duan; Yin Wang; Weiping Hu; Ning Wang; Qingyi Sun; Qingyan Liu; Xiaocong Liu; Xianghua Hou; Ao Cheng; Guixiu Shi; Yanlin Zhang
Journal:  Mediators Inflamm       Date:  2016-09-22       Impact factor: 4.711

5.  Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Tsung-Chieh Yao; Su-Hsun Liu; Jing-Long Huang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis.

Authors:  Mengmeng Xiang; Yang Feng; Yilun Wang; Jie Wang; Zhixiong Zhang; Jun Liang; Jinhua Xu
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

7.  B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis.

Authors:  Desmond Y H Yap; Susan Yung; Paul Lee; Irene Y L Yam; Cheryl Tam; Colin Tang; Tak Mao Chan
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.